Association of platelet-derived microparticles with C-C chemokines on vascular complication in patients with acute myocardial infarction

Clinical and Applied Thrombosis/Hemostasis

Volumn 8, Issue 3, 2002, Pages 279-286

  Matsumoto, Noriko ^a   Nomura, Shosaku ^a   Kamihata, Hiroshi ^a   Kimura, Yutaka ^a   Iwasaka, Toshiji ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute myocardial infarction; C C chemokine; Platelet derived microparticle; PTCA

Indexed keywords

ANTIGEN; BETA CHEMOKINE; BIOLOGICAL MARKER; CD63 ANTIGEN; FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; RANTES;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STENT; THROMBOCYTE ACTIVATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0036658528     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960200800313     Document Type: Article

References (38)

1. Frink RJ, Rooney PA, Trowbridge JO, et al. Coronary thrombosis and platelet/fibrin microemboli in death associated with acute myocardial infarction. Br Heart J 1988;59:196.
2. Wilerson JT, Golino P, Edit J, et al. Specific platelet mediators and unstable coronary artery lesions: Experimental evidence and potential clinical implications. Circulation 1989;80:198.
3. Trip MD, Cats VM, Van Capelle FJL, et al. Platelet hyper-reactivity and prognosis in survivors of myocardial infarction. N Engl J Med 1990;322:1549.
4. Koenig W, Ernst E. The possible role of hemorheology in atherothrombogenesis. Atherosclerosis 1992;94:93.
5. Daae LW, Kierulf P, Landass S, et al. Cardiovascular risk factors: Interactive effects of lipid, coagulation, and fibrinolysis. Scand J Clin Lab Invest 1993;53:19.
6. Fitzgerald DJ, Roy I, Catella F, et al. Platelet activation in unstable angina. N Engl J Med 1986;315:983.
7. Steele PM, Chesebro JH, Stanson AW, et al. Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model. Circ Res 1985;57:105.
8. Tschope D, Schultheig HP, Kolarov P, et al. Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Circulation 1993;88:37.
9. Gawaz M, Neumann F, Ott I, et al. Platelet function in acute myocardial infarction treated with direct angioplasty. Circulation 1996;93:229.
10. Abrams CHS, Ellison N, Budzynski AZ, et al. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 1990;75:128.
11. Tschope D, Esser J, Schwippert B, et al. Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Haemost 1991;17:433.
12. George JN, Thoi LL, McManus LM, et al. Isolation of human platelet membrane microparticles from plasma and serum. Blood 1982;60:834.
13. Sims PJ, Faioni EM, Wiedmer T, et al. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 1988;263:18205.
14. Nomura S, Komiyama Y, Miyake T, et al. Amyloid β-protein precursor-rich platelet microparticles in thrombotic disease. Thromb Haemost 1994;72:519.
15. Nomura S, Suzuki M, Katsura K, et al. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis 1995; 116:235.
16. Dehmer GJ, Nichols TC, Bode AP, et al. Assessment of platelet activation by coronary sinus blood sampling during balloon angioplasty and directional coronary atherectomy. Am J Cardiol 1997;80:871.
17. Ernst E, Hammerschmidt DE, Bagge U, et al. Leukocytes and the risk of ischemic heart disease. JAMA 1987; 257:2318.
18. Leatham EW, Barth PM, Tooze JA, et al. Increased monocyte tissue factor expression in coronary disease. Br Heart J 1995;73:10.
19. Matsumori A, Furukawa Y, Hashimoto T, et al. Plasma levels of monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction. J Mol Cell Cardiol 1997;29:419.
20. Rollins BJ, Yoshimura T, Leonard EJ, et al. Cytokine-activated human endothelial cells synthesize and secrete a monochemoattractant, CP-1/JE. Am J Pathol 1990; 136:1229.
21. Colotta F, Borre A, Wang JM, et al. Expression of a monocyte chemotactic cytokine by human mononuclear phagocytes. J Immunol 1992;148:760.
22. Leonard EJ, Yoshimura T. Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today 1990;11:97.
23. Baggiolini M, Dewald B, Moster B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokine. Adv Immunol 1994;55:97.
24. Kameyoshi Y, Dorschner A, Mallet AI, et al. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 1992; 176:587.
25. Nomura S, Suzuki M, Kido H, et al. Differences between platelet and microparticle glycoprotein IIb/IIIa. Cytometry 1992;13:621.
26. Miyake T, Nomura S, Komiyama Y, et al. Effect of a new monoclonal anti-glycoprotein IX antibody, KMP-9, on high shear-induced platelet aggregation. Thromb Haemost 1997;78:902.
27. Nomura S, Nagata H, Oda K, et al. Effects of EDTA on membrane glycoprotein IIb-IIIa complex: Analysis using flow cytometry. Thromb Res 1987;47:47.
28. Yanabu M, Ozaki Y, Nomura S, et al. Tyrosine phosphorylation and p72syk activation by an anti-glycoprotein lb monoclonal antibody. Blood 1997;89:1590.
29. Tschope D, Spangenberg P, Esser J, et al. Flow cytometric detection of surface membrane alterations and concomitant changes in the cytoskeletal actins status of activated platelets. Cytometry 1990;11:652.
30. Murakami T, Komiyama Y, Masuda M, et al. Flow cytometric analysis of platelet activation markers CD62P and CD63 in patients with coronary artery disease. Eur J Clin Invest 1996;26:996.
31. Koch AE, Kunkel SL, Harlow LA, et al. Macrophage inflammatory protein-1: A novel chemokine cytokine for macrophages in rheumatoid arthritis. J Clin Invest 1994; 93:921.
32. Pattison J, Nelson PJ, Huie P, et al. RANTES chemokine expression in cell-mediated transplant rejection of the kidney. Lancet 1994;343:209.
33. Cocchi F, DeVico AL, Garzino-Demo A, et al. Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995;270:1811.
34. Holme PA, Muller F, Solum NO, et al. Enhanced activation of platelets with abnormal release of RANTES in HIV-1 infection. FASEB J 1998;12:79.
35. Weyrich AS, Elstad MR, McEver RP, et al. Activated platelets signal chemokine synthesiss by human monocytes. J Clin Invest 1996;97:1525.
36. Neumann F-J, Marx N, Gawaz M, et al. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation 1997;95:2387.
37. Miyazaki Y, Nomura S, Miyake T, et al. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood 1996;88:3456.
38. Venturini CM, Kaplan JE. Thrombin induces platelet adhesion to endothelial cells. Semin Thromb Hemost 1992; 18:275.